Academic Health Center
Stay Connected
research-and-clinical-trials

Study of colleges identifies gaps in efforts to enforce alcohol laws

Photo courtesy Flickr user soursob

A new study from the University of Minnesota reveals campus security law enforcement officials are not likely to issue citations to students for alcohol-law violations.

The study published in the journal Alcoholism: Clinical & Experimental Research asked directors of campus police and security from 343 colleges across the nation to complete a survey regarding their usual practices following serious, underage, and less-serious alcohol incidents on and off campus.

Read more
research-and-clinical-trials

U of M study finds health insurance coverage and racial disparities exist in receiving reconstruction after mastectomy

A University of Minnesota School of Public Health study found health insurance coverage and racial disparities exist in women who have undergone reconstruction after mastectomy. In 2013, more than 232,000 women were diagnosed with breast cancer in the United States, and 37 percent of those women with breast cancer underwent a mastectomy, or the surgical removal of breast tissue. Of those, nearly one third undergo breast reconstruction to rebuild the shape of the removed breast. Breast reconstruction after mastectomy offers clinical, cosmetic and psychological benefits with low medical risk.

Study findings were recently published in Women’s Health Issues.

Read more
research-and-clinical-trials

Sen. Jeremy Miller impressed with U and MnDRIVE Neuromodulation research

Sen. Miller stands with President Eric Kaler during his recent visit to U of M.

In late June, the U of M hosted Minnesota Senator Jeremy Miller for an educational visit to learn more about the exciting neuromodulation research and technology taking place as part of the MnDRIVE brain conditions initiative.

During his visit Sen. Miller had the opportunity to tour the campus, meet and welcome new Minnesota men’s basketball coach Richard Pitino and hear from students and faculty about their research.

“I believe it’s extremely important for legislators, especially those on the higher education committee, to see and understand what our higher education institutions are doing,” Miller said.

Read more
research-and-clinical-trials

U of M research: Implications of expanding indications for drug treatment to prevent fracture in older men

Photo: Joan Sorolla via Flickr

A new University of Minnesota-led study of osteoporosis in men recently published in the British Medical Journal found the proportion of older men labeled as abnormal and warranting drug treatment ranged from 2 percent to 25 percent depending on the definition of osteoporosis and absolute fracture risk intervention thresholds applied to the population.

Older men experience 29 percent of all bone fractures among United States adults 50 years of age or older. However, the best strategy to identify men who are candidates for drug treatment is not yet known. The uncertainty exists, in part, because osteoporosis is not as well defined for men as it is for women. In addition, drug treatment in women with osteoporosis reduces risk of bone fractures, but the effect of treatment on fracture risk has not been evaluated in men.

Read more
news-and-notes

Chronic stress, depressive symptoms, and hostility associated with increased risk of stroke

Photo courtesy Flickr user hapal

A new study from the University of Minnesota links negative emotions with significantly increased risk of stroke or transient ischemic attacks (TIAs, or mini strokes) in middle-aged and older adults.

The results are published in the latest edition of the American Heart Association journal Stroke.

Read more
research-and-clinical-trials

New compound shows promise in treating chronic pain

Photo: Geraint Rowland/Flickr CC 3.0/flic.kr/p/82icD5

A new compound in development at the University of Minnesota shows promise as a breakthrough drug for treating chronic pain.

The new compound, developed by Philip Portoghese, Ph.D., of the University of Minnesota’s College of Pharmacy, appears to be the first of its kind. A patent has been applied for, and the University’s Center for Translational Medicine has been conducting proof-of-concept studies. As a potential medication, the compound offers benefits lacked by current medications: It does not induce the body to develop tolerance or dependence, as opioid painkillers do. It is more potent than other opioid pain medications. It reduces and inhibits neuropathic pain, post-operative pain, burn pain, spinal injury pain and inflammation.

Read more